UL Unilever PLC

Dividend
4.18%
Previous close
$55.45
Est. 12 months change
-
Projected Price
-

Profitability Metrics

Return on Equity (ROE)
42.64%
Return on Assets (ROA)
10.61%
Return on Invested Capital (ROIC)
13.79%
Weighted Average Cost of Capital (WACC)
5.31%
ROIC - WACC
8.48%
Updated : 2026-04-03 21:36 ET

Valuation Metrics

P/E Ratio
11.01
Forward P/E
15.19
PEG Ratio
31.50
Debt Current Ratio
0.79

Growth & Cash Flow

Gross Margin
46.95%
Operating Margin
20.07%
FCF Margin
13.48%
TTM Revenue Growth
-16.56%
Projected 12M EPS Growth
-27.54%

Price Change

Price % from 50 SMA
-17.58%
Price % from 200 SMA
-18.11%
6 Months
-16.37%
1 Year
-17.66%
2 Years
-0.12%
Click here to see the list of ETFs containing UL as a top holding :Unilever PLC ETFs

Analysis

Company Overview

Unilever is a global consumer goods company producing food, cleaning products, and personal care items under well-known brands including Dove, Hellmann's, Ben & Jerry's, and Lipton. Sector: Consumer Staples.

Overview

Unilever PLC (UL) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

Assessing the quality of returns on invested capital, ROIC is 13.79%, WACC is 5.31%, and the economic spread is 8.48%. On balance, the economic spread is thin but positive — the company is clearing the hurdle, though without significant headroom. Supporting metrics show ROE at 42.64% and ROA at 10.61%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that is value-creative but with less room for execution slippage.

Valuation

The market currently prices the company at trailing P/E of 11.01, forward P/E of 15.19, PEG of 31.50. The gap between P/E and forward P/E is small, suggesting the valuation is not contingent on a near-term earnings step-change. The PEG ratio signals premium pricing — the company's earnings growth expectations, while present, do not fully explain the current multiple on a purely quantitative basis. The current ratio of 0.79 is below average, suggesting some the company may face tighter short-term financial conditions. Valuation and liquidity together frame a company where the price paid today is a reasonable bet on earnings delivery — but not a margin-of-safety purchase at current levels.

Margins & Cash Generation

Looking at margins from gross to free cash flow, gross margin sits at 46.95%, operating margin at 20.07%, and free cash flow margin at 13.48%. Gross margins are constructive — not exceptional, but indicative of businesses with reasonable unit economics. At this level, operating margins reflect businesses that are scaling with discipline without dramatic cost pressure. The company's cash conversion is middle-of-the-road — sufficient for operational needs, but leaving limited surplus for discretionary allocation. Margins indicate a company that is operating effectively in some areas while still showing efficiency gaps in others.

Growth & Forward Outlook

On the growth front, TTM revenue growth of -16.56% suggesting the company is collectively facing revenue headwinds. Projected 12-month EPS growth of -27.5% is a meaningful caution flag — declining earnings expectations add pressure to the valuation case and limit the margin of safety. Reported revenue growth captures operational reality directly, without the added uncertainty of embedded analyst assumptions. The durability of the revenue trajectory will be the primary factor in determining whether the current setup translates into meaningful near-term returns.

Conclusion

Taken as a whole, the profile carries enough risk factors to suggest the margin of safety is thin at current levels — caution is advisable until the fundamental picture improves.

The analysis above draws from quantitative data only and does not constitute personalized financial advice. Investors should conduct independent research and consider professional guidance before acting on any information presented here.